Loading…

S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN PATIENTS WITH HIGH-RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS

Saved in:
Bibliographic Details
Published in:HemaSphere 2023-08, Vol.7 (S3), p.e5547136
Main Authors: Sureda, Anna, Falchi, Lorenzo, Leppa, Sirpa, Vermaat, Joost, Holte, Harald, Hutchings, Martin, Lugtenburg, Pieternella, de Vos, Sven, Abrisqueta, Pau, Nijland, Marcel, Merryman, Reid W., Christensen, Jacob Haaber, Wahlin, Bjorn, Linton, Kim, Wang, Liwei, Abbas, Aqeel, Rana, Ali, Quadri, Syed, Belada, David
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000967800.55471.36